Metformin hydrochloride for heart failure

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 24 Jun 2026: Trial registered, NCT07666698
  2. 1 Jul 2026: Trial started, NCT07666698

The trials

NCT07666698: A Study of Metformin to Improve Cardiac Function After LVAD Implantation

State
Under way
Phase
Phase 1 and Phase 2
People
108 planned
Started
1 Jul 2026
Primary completion
Jul 2028
Arms
Metformin Group
Results
None posted
  1. 24 Jun 2026: Trial registered
  2. 1 Jul 2026: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

About the treatment

Kind of treatment: Drug.

Also known as Apophage, Benofomin, Diabefagos, Diabex, Extended Release Metformin Hydrochloride, Fortamet, Glucaminol, Glucophage, Glucophage xr, Glucovance component metformin hydrochloride, Glumetza, Invokamet component metformin hydrochloride, Janumet component metformin hydrochloride, Kazano component metformin hydrochloride, Metformin XR, Metformin hydrochloride (HCl) 500mg tablet, Neodipa, Qternmet component metformin hydrochloride, Qternmet xr component metformin hydrochloride, Riomet, Riomet er, Segluromet component metformin hydrochloride, Siamformet, Trijardy xr component metformin hydrochloride, Walaphage, Xigduo component metformin hydrochloride, Zituvimet component metformin hydrochloride.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.